WO1997045741A1 - Immunoelectrode dans l'ecoulement du fluide pour immunodosage amperometrique rapide - Google Patents
Immunoelectrode dans l'ecoulement du fluide pour immunodosage amperometrique rapide Download PDFInfo
- Publication number
- WO1997045741A1 WO1997045741A1 PCT/US1997/008587 US9708587W WO9745741A1 WO 1997045741 A1 WO1997045741 A1 WO 1997045741A1 US 9708587 W US9708587 W US 9708587W WO 9745741 A1 WO9745741 A1 WO 9745741A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- flow
- immuno
- electrode
- cell
- analyte
- Prior art date
Links
- 238000003018 immunoassay Methods 0.000 title abstract description 29
- 238000000034 method Methods 0.000 claims abstract description 42
- 239000012491 analyte Substances 0.000 claims abstract description 24
- 239000000243 solution Substances 0.000 claims abstract description 23
- 239000000463 material Substances 0.000 claims abstract description 16
- 239000000758 substrate Substances 0.000 claims abstract description 9
- 230000027455 binding Effects 0.000 claims abstract description 8
- 239000003547 immunosorbent Substances 0.000 claims description 36
- 239000007788 liquid Substances 0.000 claims description 21
- 239000002245 particle Substances 0.000 claims description 15
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims description 13
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- 239000012528 membrane Substances 0.000 claims description 7
- 238000006243 chemical reaction Methods 0.000 claims description 6
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims description 4
- 239000010931 gold Substances 0.000 claims description 4
- 229910052737 gold Inorganic materials 0.000 claims description 4
- 239000010439 graphite Substances 0.000 claims description 4
- 229910002804 graphite Inorganic materials 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 230000002452 interceptive effect Effects 0.000 claims description 2
- 239000013626 chemical specie Substances 0.000 claims 6
- 239000002250 absorbent Substances 0.000 claims 3
- 238000003556 assay Methods 0.000 abstract description 27
- 102000004190 Enzymes Human genes 0.000 abstract description 14
- 108090000790 Enzymes Proteins 0.000 abstract description 14
- 238000004401 flow injection analysis Methods 0.000 abstract description 9
- 238000005259 measurement Methods 0.000 abstract description 7
- 238000006911 enzymatic reaction Methods 0.000 abstract description 4
- 239000011521 glass Substances 0.000 abstract description 4
- 229940127121 immunoconjugate Drugs 0.000 abstract description 4
- 239000004033 plastic Substances 0.000 abstract description 4
- 239000000123 paper Substances 0.000 abstract description 3
- 230000002860 competitive effect Effects 0.000 abstract description 2
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 15
- 229940027941 immunoglobulin g Drugs 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 239000000427 antigen Substances 0.000 description 11
- 102000036639 antigens Human genes 0.000 description 11
- 108091007433 antigens Proteins 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 10
- 230000004044 response Effects 0.000 description 10
- 239000000725 suspension Substances 0.000 description 9
- 238000004458 analytical method Methods 0.000 description 8
- UQLDLKMNUJERMK-UHFFFAOYSA-L di(octadecanoyloxy)lead Chemical compound [Pb+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O UQLDLKMNUJERMK-UHFFFAOYSA-L 0.000 description 8
- 238000001514 detection method Methods 0.000 description 7
- 229920001213 Polysorbate 20 Polymers 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 5
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000009518 sodium iodide Nutrition 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 241000150452 Orthohantavirus Species 0.000 description 3
- 102000003992 Peroxidases Human genes 0.000 description 3
- 230000009830 antibody antigen interaction Effects 0.000 description 3
- 210000004027 cell Anatomy 0.000 description 3
- 230000008021 deposition Effects 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 238000006073 displacement reaction Methods 0.000 description 3
- 230000003287 optical effect Effects 0.000 description 3
- 108040007629 peroxidase activity proteins Proteins 0.000 description 3
- 239000007974 sodium acetate buffer Substances 0.000 description 3
- MWOOKDULMBMMPN-UHFFFAOYSA-N 3-(2-ethyl-1,2-oxazol-2-ium-5-yl)benzenesulfonate Chemical compound O1[N+](CC)=CC=C1C1=CC=CC(S([O-])(=O)=O)=C1 MWOOKDULMBMMPN-UHFFFAOYSA-N 0.000 description 2
- 244000186140 Asperula odorata Species 0.000 description 2
- 101100459438 Caenorhabditis elegans nac-1 gene Proteins 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 235000008526 Galium odoratum Nutrition 0.000 description 2
- 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 239000003153 chemical reaction reagent Substances 0.000 description 2
- 230000009137 competitive binding Effects 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- 210000002381 plasma Anatomy 0.000 description 2
- 108090000765 processed proteins & peptides Proteins 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- 239000012429 reaction media Substances 0.000 description 2
- 230000035945 sensitivity Effects 0.000 description 2
- 230000019491 signal transduction Effects 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- HGUFODBRKLSHSI-UHFFFAOYSA-N 2,3,7,8-tetrachloro-dibenzo-p-dioxin Chemical compound O1C2=CC(Cl)=C(Cl)C=C2OC2=C1C=C(Cl)C(Cl)=C2 HGUFODBRKLSHSI-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 1
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 1
- 101710162629 Trypsin inhibitor Proteins 0.000 description 1
- 229940122618 Trypsin inhibitor Drugs 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 238000000429 assembly Methods 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000002981 blocking agent Substances 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 230000006957 competitive inhibition Effects 0.000 description 1
- 230000009918 complex formation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000000835 electrochemical detection Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 238000003119 immunoblot Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000013208 measuring procedure Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000009871 nonspecific binding Effects 0.000 description 1
- 239000013612 plasmid Substances 0.000 description 1
- 229920001184 polypeptide Polymers 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000011896 sensitive detection Methods 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000007790 solid phase Substances 0.000 description 1
- 230000009870 specific binding Effects 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- 239000002753 trypsin inhibitor Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54373—Apparatus specially adapted for solid-phase testing involving physiochemical end-point determination, e.g. wave-guides, FETS, gratings
- G01N33/5438—Electrodes
Definitions
- This invention relates to sensors for detecting and quantifying a target analyte via immunological based reactions, and more particularly to a flow through amperometric sensor.
- Immunoassay techniques are based on the ability of antibodies to form complexes with the corresponding antigens. This property of highly specific molecular recognition of antigens by antibodies leads to high selectivity of assays based on immune principles. The high affinity of antigen-antibody interactions allows very small quantities of a target analyte to be determined. Contemporary immunological techniques allow production of antibodies against a great number of antigens, and enables immunoanalysis of many substances such as low molecular weight drugs, short peptides, toxins, as well as polypeptides, proteins, viruses and bacteria.
- Immunoassay techniques are used mainly in clinical analyses and medical diagnostics. Immunoassay techniques could, in principle, be utilized in many non-clinical applications if assay systems that were better adapted for field conditions were available.
- an immuno-sensor (biosensor) consists of a signal transducer and a biochemically interactive system employing principles of biological molecular recognition. Based on the nature of the physical detection used in the transducer, immuno-sensing systems can be classified as optical, gravimetric and electrochemical. In optical transducers, detection is based on light-sensitive elements. The optical signal detection can be conducted by spectrophotometric, spectrofluorimetric, hemiluminometric, reflectometric or other related techniques.
- Gravimetric transducers are based on sensitive detection of mass changes following antigen-antibody complex formation.
- Piezoelectric detectors are typically based on acoustical resonators having resonant frequencies that are altered by the change in mass of a layer which is in contact with the resonator. This layer typically includes one member of an antigen- antibody complex. When the other member attaches to the layer, the resonance frequency shifts. These transducers cannot distinguish between specific binding and non-specific binding.
- Electrochemical transducers are based on detection of changes in electro transfer caused by the immuno-interaction. In particular, this detection is brought about using amperometric, poteniometric, conductometric (at constant voltage) or impedimetric (at alternative voltage) devices.
- Flow-injection principles can be used to enhance the efficiency of the immuno- interaction.
- Prior art flow-injection immuno-sensing systems are based on a principle of displacement.
- the immunoassay system is arranged as a column containing immobilized antibodies.
- the column is saturated with a solution containing labeled antigen.
- the column contains a solid carrier with immobilized antibody-labeled antigen complexes.
- the affinity of antibodies for labeled antigens is usually significantly lower than their affinity for unlabeled (free) antigen due to stearic factors. Therefore, injection of free antigen into the column results in displacement of the labeled by the unlabeled antigen. Labeled antigen then is detected at the outlet of the column.
- a similar scheme can be realized based on the use of immobilized antigen. In this case, injection of the analyte leads to replacement of antibody conjugated complex.
- Another object of the invention is to provide a portable immuno-sensor capable to detect both (i) high molecular weight and (ii) low molecular weight target analytes under non- laboratory conditions.
- the present invention is an electrode and measuring cell for fast flow immunoassay of a wide range of analytes.
- the high surface area electrode comprises an electroconductive material with immobilized immuno-species deposited on glass, paper or plastic filter.
- the solution containing the target analyte and/or the enzyme labeled immunoconjugate flows through the electrode.
- the assay procedure is based on a competitive or 'sandwich' scheme.
- the immuno-interaction between the immobilized immunospecies target analyte and the enzyme labeled immunoconjugate results in binding of the enzyme label to the electrode surface.
- the assay of the enzyme label is performed by flow injection of the corresponding enzyme substrate, and amperometric measurement of the product of the enzymatic reaction.
- the measuring cell is equipped with an inlet, outlet, a reference electrode, a counter electrode, and a current collector attached to a disposable flow immuno-electrode.
- Figure 1 is a schematic drawing of a flow-through sensor system according to the present invention.
- Figure 2 is a cross-sectional view of an assay apparatus according to the present invention.
- Figure 3 is an exploded cross-sectional view of assay probe 50 shown in Figure 2.
- the present invention comprises a flow-through system in which the immuno- electrode utilizes a highly dispersed electro-conductive immuno-sorbent which also provides the immuno-electrode function. That is, the immuno-column doubles as the electrochemical transducer.
- the highly dispersed material comprising the immuno-sorbent provides a high surface area-to- volume ratio which, in turn, provides a high rate of immuno-complex formation.
- the high conductivity of the immuno-sorbent material allows the electrochemical detection of the enzyme label directly in the column. Therefore, the present invention provides the advantages of both the flow-immunoassay techniques and techniques that utilize immuno-electrodes.
- FIG. 1 is a schematic drawing of a flow-through sensor system 10 according to the present invention.
- System 10 utilizes a miniature immuno-column 17 which includes a highly dispersed immuno-sorbent 15 which acts as a working (measuring) electrode.
- the current generated by the electrodes discussed below is measured by measurement assembly 16 which also includes conventional control circuitry for operating the various other components of the system. To simplify the drawing, the connections between measurement assembly 16 and the various other components have been omitted from the drawing.
- Immuno-column 17 serves as both an immuno-reactor and an electrochemical measuring cell.
- Immuno-column 17 includes an inert body which supports a porous filter membrane 18.
- the immuno-sorbent 15 is deposited upon the filter membrane 18.
- Filter membrane 18 is preferably constructed from glass, paper, or plastic.
- the manner in which the system shown in Figure 1 is used may be more easily understood with reference to performing a conventional 'sandwich' immuno-analysis for a target analyte, X.
- the immuno-sorbent 15 is assumed to be loaded with antibodies to X which are immobilized on the particles of the immuno-sorbent at the start of the assay.
- the sample is injected into immuno-column 17 via sample port 13 and valve assembly 12 in a suitable carrier liquid.
- Valve Assembly 12 may include a pump for moving the various fluids through the column. If molecules of X are present in the sample, they are bound to the immuno-sorbent by the antibodies attached to the particles. A second solution containing antibody to X is then introduced into the immuno-column from reservoir 22.
- These antibodies are labeled with an enzyme that catalyzes a reaction involving a substrate Y.
- an enzyme that catalyzes a reaction involving a substrate Y.
- the immuno-column 17 is washed with carrier liquid from reservoir 24 to remove any unbound labeled antibody.
- a solution containing substrate Y is then introduced into immuno-column 17 from reservoir 23.
- the amperometric output from the electrodes is measured by assembly 16. The output is the current between the working and counter electrodes generated when the potential between the working and reference electrodes is maintained at a constant value.
- the amperometric output is proportional to the concentration of the product of enzymatic reaction and therefore, proportional to the amount of the enzyme label bound to the immuno-sorbent.
- the bound concentration of bound enzyme is proportional to the amount of X bound to the column.
- the present invention may also be used to perform assays based on competitive inhibition of the antibody binding.
- the immuno-sorbent is loaded with X', a compound that binds antibody to X via a group that is similar in configuration to X.
- the presence of X will inhibit the binding of antibody to X'.
- X and antibody to X' are introduced into the column.
- the antibody to X' is labeled with the substrate. After the washing step described above, the amount of labeled antibody is measured as described above by introducing Y into the column and measuring the output from the electrodes.
- a variant of the sensor arrangement involves a current collector 19 affixed above the immuno-sorbent layer 15 in intimate contact with the later.
- the current collector 19 is used to uptake the amperometric signal from the immuno-sorbent layer 15 which may be viewed as an immuno-electrode, polarized as working electrode in amperometric mode.
- the current collector 19 consists of a conductive probe made from electrochemically inert material (such as carbon, graphite, gold, etc.).
- the immuno-column is a disposable assembly which is connected to the various electrodes when the column is attached to a non-disposable portion of the apparatus.
- Figures 2 and 3 Such an embodiment is shown in Figures 2 and 3 at 50.
- Figure 2 is a cross-sectional view of an assay apparatus according to the present invention.
- Figure 3 is an exploded cross-sectional view of assay probe 50.
- Assay probe 50 is constructed from three sub-assemblies shown at 60. 70, and 80, respectively.
- the immuno-column sub-assembly 60 is a disposable unit which includes the immuno-sorbent 63 on a filter membrane 62 which is supported on an insulating plastic subort 61.
- the immuno- column assembly fits into a reference electrode assembly 70 which includes the reference electrode 65 and counter electrode 64.
- the working electrode assembly 80 fits into the immuno-electrode assembly and provides the working electrode 66 which is preferably constructed from carbon.
- a flow tube 67 provides the connection through which the sample is pumped through the immuno-column.
- the flow tube may be constructed from a glass capillary tube.
- the electrodes contributing to the amperometric signal transduction: the working (measuring) electrode represented by flow immuno-sorbent layer 15, the reference electrode 20 and (or) the counter electrode 21 are in contact with the liquid flowing through the sensor assembly. Both a three electrode circuit scheme (with working electrode 15. counter 21 and reference electrodes 20) and a two electrode circuit scheme (with working electrode 15 and reference electrodes 20 where the reference electrode serves as a counter electrode as well) for the amperometric signal transduction can be employed.
- Example 1 Determination of rabbit IgG utilizing a 'sandwich' assay scheme.
- Immunoassay procedure The assay system was assembled by connecting the immuno-column to the liquid stream. The current collector was attached to the immuno- electrode. Then a sample containing target analyte (rabbit IgG) is introduced into the liquid stream formed by 0.01 M Na-phosphate buffer (pH 7.4), containing 0.15 M NaCl and 0.05% Tween-20 (PBST) and flows (for 2 minutes) through immuno-column. PBST containing peroxidase labeled antibodies against rabbit IgG (1 :50 diluted) is then allowed to flow through the immuno-column for 5 minutes. Then washing solution (PBST alone) is then allowed to flow through the immuno-column in order to remove unbound labeled antibodies.
- PBST peroxidase labeled antibodies against rabbit IgG
- Example 2 Determination of rabbit IgG utilizing a competitive binding protocol.
- Immuno-sorbent preparation The immobilization of rabbit IgG on ULTI carbon was performed using Woodward's reagent by the method described above with reference to Example 1 to form the immuno-sorbent. Immuno-electrode was prepared by deposition of the immuno-sorbent suspension in the immuno-column and centrifugation.
- Immunoassay procedure The assay system was assembled by connecting the immuno-column to the liquid stream.
- the current collector was attached to the immuno- electrode.
- a sample containing mixture of a target analyte (rabbit IgG) and peroxidase labeled antibodies against rabbit IgG (1 :400 diluted) was introduced into the liquid stream formed by 0.01 M Na-phosphate buffer (pH 7.4), containing 0.15 M NaCl and 0.05% Tween- 20 (PBST) and was allowed to flow for 8 minutes through immuno-column.
- PBST 0.15 M NaCl and 0.05% Tween- 20
- the solution containing 1 mM sodium iodide in of 0.1 M sodium acetate buffer containing 0.05% Tween-20 and 1 mM H 2 0 2 was allowed to flow through immuno-column.
- the amperometric output was measured while the sodium iodide solution flowed through the immuno-column.
- the flow rate at all the stages of the assay was 0.09 ml/min.
- the sensor response is obtained by the method described above (see Example 1).
- the immuno-electrode response was found to be inversely proportional to the concentration of rabbit IgG as expected.
- Example 3 Determination of antibodies against Hantavirus in human blood plasma.
- the recombinant nucleocapsid protein was formed from expression of plasmid constructs with the complete nucleocapsid gene in E. coli.
- the product is a fusion protein with matose binding protein that is purified by passage through amaltose affinity column.
- the immobilization of recombinant protein of Hantavirus on ULTI carbon was performed using Woodward's reagent by the method described above with reference to Example 1.
- the immuo-electrode was prepared by deposition of the immuno-sorbent suspension in the immuno-column and centrifugation.
- Immunoassay procedure The assay system was assembled by connecting the immuno-column to the liquid stream. The current collector was attached to the immuno- electrode. Then a blood plasma sample (diluted by PBST 1 :2) was introduced into the liquid stream and allowed to flow for 2 minutes through the immuno-column. PBST containing peroxidase labeled antibodies against human IgG (1 :50 diluted) was then allowed to flow through the immuno-column for 5 minutes. The immuno-column was then washed (PBST alone) for 2 minutes.
- the sensor response was then measured while a solution containing 1 mM sodium iodide in of 0.1 M sodium acetate buffer containing 0.05% Tween-20 and 1 mM H 2 0 2 flowed through the immuno-column.
- the flow rate of all the stages of the assay was 0.09 ml/min.
- the sensor response to negative blood sample is practically the same as the control background response obtained for buffer solution.
- the Hantavirus positive blood sample demonstrates an electrode response about 5 times higher than the background sensor response.
- immuno-columns can be provided as disposable units.
- the cost of such columns is minimal, since the structural members and electrodes may be constructed from inexpensive materials and the amount of material is small.
- Systems that are partially disposable will also be apparent to those skilled in the art from the above discussion.
- a disposable element comprising the immuno-electrode element comprising the immuno-sorbent coated particles on a filter membrane may be utilized.
- the actual connection to current collector 19 may be made by a contact in the wall of the immuno-column.
- a more complex disposable unit that includes electrodes 20 and/or 21 may also be provided.
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention concerne une électrode (15, 19) ainsi qu'une cellule de mesure (17, 50) destinée à l'immunodosage rapide en écoulement d'une vaste gamme de produits à analyser. L'électrode de grande superficie (15, 19) est constituée d'un matériau électroconducteur. Des immuno-espèces immobilisées sont déposées sur un filtre en verre, en papier ou en plastique (18, 62). La solution contenant le produit cible à analyser et/ou l'immunoconjugué s'écoule par l'électrode (15, 19). Le dosage se fait en mode compétitif ou sandwich. Il résulte de l'interaction immunitaire entre le produit cible à analyser contenant les immuno-espèces immobilisées et l'immunoconjugué marqué par une enzyme une liaison de l'enzyme de marquage sur la surface d'électrode. Le dosage de l'enzyme de marquage se fait selon la technique FIA pour le substrat de l'enzyme correspondante, à la suite de quoi on effectue une mesure ampérométrique du produit de la réaction enzymatique.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU31360/97A AU3136097A (en) | 1996-05-29 | 1997-05-20 | Flow-through immuno-electrode for fast amperometric immunoassays |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US1856696P | 1996-05-29 | 1996-05-29 | |
US60/018,566 | 1996-05-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO1997045741A1 true WO1997045741A1 (fr) | 1997-12-04 |
Family
ID=21788595
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US1997/008587 WO1997045741A1 (fr) | 1996-05-29 | 1997-05-20 | Immunoelectrode dans l'ecoulement du fluide pour immunodosage amperometrique rapide |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU3136097A (fr) |
WO (1) | WO1997045741A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001027626A3 (fr) * | 1999-10-01 | 2001-10-18 | Biopreventive Ltd | Moyens permettant d'effectuer des dosages immunologiques et systeme comprenant ces moyens |
WO2009036931A1 (fr) | 2007-09-18 | 2009-03-26 | Eads Deutschland Gmbh | Dispositif et procédé pour régénérer des biocapteurs |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281539A (en) * | 1989-10-02 | 1994-01-25 | The Regents Of The University Of Michigan | Immunoassay device for continuous monitoring |
-
1997
- 1997-05-20 AU AU31360/97A patent/AU3136097A/en not_active Abandoned
- 1997-05-20 WO PCT/US1997/008587 patent/WO1997045741A1/fr active Application Filing
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5281539A (en) * | 1989-10-02 | 1994-01-25 | The Regents Of The University Of Michigan | Immunoassay device for continuous monitoring |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001027626A3 (fr) * | 1999-10-01 | 2001-10-18 | Biopreventive Ltd | Moyens permettant d'effectuer des dosages immunologiques et systeme comprenant ces moyens |
WO2009036931A1 (fr) | 2007-09-18 | 2009-03-26 | Eads Deutschland Gmbh | Dispositif et procédé pour régénérer des biocapteurs |
EP2191270B1 (fr) * | 2007-09-18 | 2013-07-24 | EADS Deutschland GmbH | Dispositif et procédé pour régénérer des biocapteurs |
Also Published As
Publication number | Publication date |
---|---|
AU3136097A (en) | 1998-01-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4713347A (en) | Measurement of ligand/anti-ligand interactions using bulk conductance | |
Bunde et al. | Piezoelectric quartz crystal biosensors | |
Ghindilis et al. | Immunosensors: electrochemical sensing and other engineering approaches | |
O'sullivan et al. | Piezoelectric immunosensors-theory and applications | |
Stefan et al. | Immunosensors in clinical analysis | |
US4789804A (en) | Analytical device and method utilizing a piezoelectric crystal biosensor | |
AU621291B2 (en) | Assay method and device | |
Su et al. | Design and application of piezoelectric quartz crystal-based immunoassay | |
Lu et al. | A reusable and specific protein A‐coated piezoelectric biosensor for flow injection immunoassay | |
Harteveld et al. | Detection of staphylococcal enterotoxin B employing a piezoelectric crystal immunosensor | |
Uttenthaler et al. | Characterization of immobilization methods for African swine fever virus protein and antibodies with a piezoelectric immunosensor | |
König et al. | Development of a piezoelectric immunosensor for the detection of human erythrocytes | |
EP0363401A1 (fr) | Detecteur capacitif optimise pour des analyses et des mesures chimiques | |
Kumar | Biosensors based on piezoelectric crystal detectors: theory and application | |
US7931788B1 (en) | Method and apparatus for the detection of pathogens, parasites, and toxins | |
Le et al. | A goat-anti-human IgG modified piezoimmunosensor for Staphylococcus aureus detection | |
Puchades et al. | Recent developments in flow injection immunoanalysis | |
Krishnan et al. | Fast amperometric immunoassay for hantavirus infection | |
Sakai et al. | Selective and repeatable detection of human serum albumin by using piezoelectric immunosensor | |
Bojorge Ramírez et al. | The evolution and developments of immunosensors for health and environmental monitoring: problems and perspectives | |
Medyantseva et al. | Immunosensors in biology and medicine: analytical capabilities, problems, and prospects | |
Killard et al. | Rapid antibody biosensor assays for environmental analysis | |
Vetcha et al. | Portable Immunosensor for the Fast Amperometric Detection of Anti‐Hantavirus Antibodies | |
Cooper et al. | The nature of biosensor technology | |
US20010006825A1 (en) | Method for detecting or assaying target substance by utilizing oxygen electrode |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): AU CA JP |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE |
|
DFPE | Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101) | ||
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
NENP | Non-entry into the national phase |
Ref country code: JP Ref document number: 97542673 Format of ref document f/p: F |
|
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: CA |